Albireo is a global biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases. As leader in bile acid biology, we leverage our expertise in bile acid modulation with the goal of providing hope for families by delivering potentially transformative medicines. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden.
